Through
9/15
Addiction Disorders
Identifying connections between adverse childhood events and substance use disorders
Identifying connections between adverse childhood events and substance use disorders
New research from Penn Medicine finds that people with anxiety and substance use disorders reported experiencing more adverse childhood experiences and lacking protective factors, such as close family connections, that can mitigate their harms.
How incentives could better treat stimulant use disorder
How incentives could better treat stimulant use disorder
Researchers at Penn Medicine are working to update contingency management protocols and dissemination practices that focus on incentivizing behavior for patients.
Humanizing the hospital experience for people with substance use disorders
Humanizing the hospital experience for people with substance use disorders
Anooshey Ikhlas, Catherine Hood, and Brianna Aguilar, winners of a 2024 President’s Engagement Prize, will work with Penn Presbyterian Medical Center to address challenges faced during hospitalization and reduce premature discharges.
Helping hospitalized patients address addiction with empathy
Helping hospitalized patients address addiction with empathy
Certified recovery specialist Eric Ezzi brings compassionate care to for patients dealing with substance use, a role that is part Penn Medicine’s efforts to address the urgent drug addiction crisis.
New Penn Medicine Nudge Unit pilots show simple questions can improve care
New Penn Medicine Nudge Unit pilots show simple questions can improve care
Experts at the Penn Medicine Center for Addiction Medicine and Policy have seen success in treatment after posing one question: “Why not treat alcohol use the same way we’ve been treating opioid use?”
One in six patients with opioid use disorder leaving the hospital before completing treatment
One in six patients with opioid use disorder leaving the hospital before completing treatment
A new Penn Medicine analysis shows that discharges too early for patients with opioid use disorder increased over 50% between 2016 and 2020.
The new U.S. plan to target xylazine-laced fentanyl
The new U.S. plan to target xylazine-laced fentanyl
Researchers from Penn LDI, in conjunction with the Center for Health Economics of Treatment Interventions for Substance Use Disorder, analyze the plan and raise the question of whether it goes far enough.
Auto-nudges increase emergency department treatment of opioid use disorder
Auto-nudges increase emergency department treatment of opioid use disorder
A Penn Medicine study finds assessment for opioid withdrawal doubles when a triage screening question is paired with electronic health record automated prompts.
Data shows disparities among alcohol use disorder diagnosis among veterans
Data shows disparities among alcohol use disorder diagnosis among veterans
New Penn Medicine research shows how AUD diagnoses differ among veterans, given evidence that exposure to trauma, including combat, is a risk factor.
The economics of addiction
The economics of addiction
Professor of Economics Jeremy Greenwood’s research is uncovering information about the opioid crisis, its effects on the labor shortage, and the law of unintended consequences.
In the News
Philadelphia Tribune
‘A system of disjointed pieces’: Philly addiction medicine experts call for reforms in substance use treatment
Margaret Lowenstein of the Perelman School of Medicine says that patients seeking substance use treatment who also have infections or wounds struggle to get into a rehab that has the capacity to care for these issues.
FULL STORY →
Philadelphia Inquirer
Drug deaths and overdoses plague Philly jails, raising concerns about plans to step up Kensington arrests
Jeanmarie Perrone of the Perelman School of Medicine says that opioid withdrawal is typically not life-threatening, but that underlying health conditions or multidrug use can result in serious complications.
FULL STORY →
Psychology Today
Fentanyl overdoses may cause brain injury
Researchers from Penn and the National Institute on Drug Abuse suggest that neurologic and cognitive impairments could interfere with a patient’s ability to engage in addiction treatment.
FULL STORY →
Philadelphia Inquirer
As wounds and amputations spike, experts say Philly’s $100M addiction treatment center must ensure adequate medical care for patients
Nicole O’Donnell of Penn Medicine says that the Parker administration’s planned addiction treatment center in Philadelphia presents an opportunity to cover currently nonexistent levels of care.
FULL STORY →
Slate.com
What’s going on with tranq?
Jeanmarie Perron of the Perelman School of Medicine says that the appearance and progression of skin ulcers and tissue loss on xylazine users is different than with other intravenous drugs.
FULL STORY →
Philadelphia Inquirer
Mayor Parker’s plan to ‘remove the presence of drug users’ from Kensington raises new questions
Shoshana Aronowitz of the School of Nursing and Ashish Thakrar of the Perelman School of Medicine comment on the lack of specificity in Philadelphia’s plan to remove drug users from Kensington and on the current state of drug treatment in the city.
FULL STORY →